Moolec Science (MLEC) EBITDA (2022 - 2024)

Moolec Science (MLEC) reported EBITDA of -$2.1 million for Q4 2024, down 14.86% on a YoY basis from -$2.4 million in Q1 2024, and up 2.0% sequentially from -$2.1 million in Q3 2024.

Moolec Science (MLEC) EBITDA (2022 - 2024) Analysis & Trends

Moolec Science (MLEC) has 3 years of EBITDA data on file, last reported at -$2.1 million in Q4 2024.

  • For the quarter ending Q4 2024, EBITDA fell 14.86% year-over-year to -$2.1 million; the trailing twelve-month figure through Dec 2024 stood at -$9.1 million (up 4.0% YoY), and the FY2024 full-year result was -$9.0 million, down 35.9% from the prior year.
  • EBITDA advanced to -$2.1 million in Q4 2024, from -$2.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$472416.0 in Q4 2022 to a low of -$4.1 million in Q2 2023.
  • A 3-year average of -$1.8 million and a median of -$1.9 million in 2023 frame the typical range for EBITDA.
  • Across the five-year window, EBITDA tumbled 279.55% in 2023 and grew 28.0% in 2024, its largest moves.
  • Tracing MLEC's EBITDA over 3 years: stood at -$472416.0 in 2022, then plunged by 279.55% to -$1.8 million in 2023, then fell by 14.86% to -$2.1 million in 2024.
  • Business Quant data shows MLEC's EBITDA at -$2.1 million in Q4 2024, -$2.1 million in Q3 2024, and -$2.9 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -27.75 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 249.90 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.72 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.14 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 642.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -32.68 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 493.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -445.22 Mn
10 Moolec Science 5.21 Bn 5.21 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.06 Mn
Sep 30, 2024 -2.10 Mn
Jun 30, 2024 -2.94 Mn
Mar 31, 2024 -2.04 Mn
Dec 31, 2023 -1.79 Mn
Sep 30, 2023 -2.27 Mn
Jun 30, 2023 -4.08 Mn
Mar 31, 2023 -1.38 Mn
Dec 31, 2022 -472,416.00
Sep 30, 2022 -718,315.00
Jun 30, 2022 -1.30 Mn
Mar 31, 2022 -519,962.00